Diversified Medical Product PortfolioPHC's broad product mix across diagnostics, medical instruments and healthcare IT supports durable demand diversification. This reduces exposure to single-product cycles, enables cross-selling to hospitals and clinics, and stabilizes revenue versus niche peers over quarters.

R&D Partnerships And Emerging Market FocusOngoing R&D collaborations and explicit expansion into emerging markets strengthen long-term innovation and addressable market. Partnerships accelerate product development and licensing, while emerging-market expansion offers structural revenue growth as healthcare infrastructure investments rise.

Strong Revenue Growth With Healthy Gross MarginsRobust TTM revenue growth combined with a ~46% gross margin indicates persistent product demand and pricing power. This margin profile supports reinvestment in R&D and capex and underpins sustainable cash generation, even if operating profitability needs improvement.

Bears Say

High Financial LeverageSignificant leverage raises interest and refinancing risk, reducing financial flexibility for capex or M&A. In a cyclical healthcare investment environment, high debt can constrain strategic moves, increase cost of capital, and amplify downside in weaker revenue periods.

Low Net ProfitabilityA low net margin versus a healthy gross margin suggests elevated operating or non-operating costs that erode shareholder returns. Persistently slim net margins limit retained earnings and cushion against shocks, and reduce internal funding for growth initiatives over time.

Weaker Free Cash Flow DynamicsDeclining FCF and a very low operating-cash-flow to net-income ratio signal earnings quality and conversion issues. This constrains long-term investment, dividend sustainability and forces reliance on debt or equity to fund expansion, exacerbating leverage concerns.

PHC Holdings Corp. News

2GY Upcoming Earnings Report: What to Expect?

PHC Holdings Corp. (2GY) is scheduled to report 2nd quarter earnings on 11/12/2025. Regarding Q2 estimates, Wall Street...

3M ago

6523 FAQ

What was PHC Holdings Corp.’s price range in the past 12 months?

PHC Holdings Corp. lowest stock price was ¥856.00 and its highest was ¥1189.00 in the past 12 months.

What is PHC Holdings Corp.’s market cap?

PHC Holdings Corp.’s market cap is ¥129.26B.

When is PHC Holdings Corp.’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were PHC Holdings Corp.’s earnings last quarter?

Currently, no data Available

Is PHC Holdings Corp. overvalued?

According to Wall Street analysts PHC Holdings Corp.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does PHC Holdings Corp. pay dividends?

PHC Holdings Corp. pays a Semiannually dividend of ¥21 which represents an annual dividend yield of 3.73%. See more information on PHC Holdings Corp. dividends here

What is PHC Holdings Corp.’s EPS estimate?

PHC Holdings Corp.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does PHC Holdings Corp. have?

PHC Holdings Corp. has 126,721,820 shares outstanding.

What happened to PHC Holdings Corp.’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of PHC Holdings Corp.?

Currently, no hedge funds are holding shares in JP:6523

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

PHC Holdings Corp.

PHC Holdings Corporation, through its subsidiaries, develops, manufactures, and sells medical devices, healthcare technology solutions, and life science products. The company offers blood glucose monitoring systems and other testing/analysis devices, as well as data linkage solutions; anatomical pathology solutions, such as instruments, microscope slides, and dyeing reagents; and equipment and services for various sample preservation and cell culture in the life sciences field. It also provides healthcare IT products in the field of medical information systems for clinics and healthcare insurance pharmacies. In addition, the company engages in clinical testing, diagnostic reagents, and drug development support businesses. The company was formerly known as Panasonic Healthcare Holdings Co., Ltd. and changed its name to PHC Holdings Corporation in April 2018. The company was founded in 2014 and is headquartered in Tokyo, Japan.